These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


258 related items for PubMed ID: 17044444

  • 1. Dyslipidemias in chronic kidney disease.
    Szromba C.
    Nephrol Nurs J; 2006; 33(5):575-6. PubMed ID: 17044444
    [No Abstract] [Full Text] [Related]

  • 2. Treating antiretroviral-induced dyslipidemia in HIV-infected adults.
    Scordo KA.
    Nurse Pract; 2010 Jul; 35(7):32-7; quiz 37-8. PubMed ID: 20555242
    [No Abstract] [Full Text] [Related]

  • 3. CE: Continuing Education article. Patient management in CKD stages 1 TO 3.
    Murphy F, Jenkins K, Chamney M, McCann M, Sedgewick J.
    J Ren Care; 2008 Sep; 34(3):127-35. PubMed ID: 18786079
    [Abstract] [Full Text] [Related]

  • 4. K/DOQI clinical practice guidelines for management of dyslipidemias in patients with kidney disease.
    Kidney Disease Outcomes Quality Initiative (K/DOQI) Group.
    Am J Kidney Dis; 2003 Apr; 41(4 Suppl 3):I-IV, S1-91. PubMed ID: 12671933
    [No Abstract] [Full Text] [Related]

  • 5. The primary target. Taking aim at LDL levels to prevent cardiovascular disease.
    Mason CM.
    Adv Nurse Pract; 2007 Dec; 15(12):55-8. PubMed ID: 20014676
    [No Abstract] [Full Text] [Related]

  • 6. Chronic kidney disease and cardiovascular disease--using the ANNA Standards and Practice Guidelines to improve care. Part 1: the epidemiology of chronic kidney disease: the risk factors and complications that contribute to cardiovascular disease.
    McCarley PB, Burrows-Hudson S.
    Nephrol Nurs J; 2006 Dec; 33(6):666-74; quiz 675-6. PubMed ID: 17219728
    [Abstract] [Full Text] [Related]

  • 7. Understanding the stages of chronic kidney disease.
    Castner D.
    Nursing; 2010 May; 40(5):24-31; quiz 31-2. PubMed ID: 20386393
    [No Abstract] [Full Text] [Related]

  • 8. Does nurse case management improve implementation of guidelines for cardiovascular disease risk reduction?
    Berra K.
    J Cardiovasc Nurs; 2011 May; 26(2):145-67. PubMed ID: 21076315
    [Abstract] [Full Text] [Related]

  • 9. Dyslipidemia after renal transplantation: a cause for concern?
    Butani L.
    Pediatr Transplant; 2008 Nov; 12(7):724-8. PubMed ID: 18444948
    [No Abstract] [Full Text] [Related]

  • 10. Managing diabetic dyslipidemia: aggressive approach.
    Spratt KA.
    J Am Osteopath Assoc; 2009 May; 109(5 Suppl):S2-7. PubMed ID: 19451254
    [Abstract] [Full Text] [Related]

  • 11. Pharmacotherapy of dyslipidemias in the adult population.
    Vigna GB, Fellin R.
    Expert Opin Pharmacother; 2010 Dec; 11(18):3041-52. PubMed ID: 20958118
    [Abstract] [Full Text] [Related]

  • 12. Management of lipid abnormalities associated with end-stage renal disease.
    Liu J, Kalantarinia K, Rosner MH.
    Semin Dial; 2006 Dec; 19(5):391-401. PubMed ID: 16970739
    [Abstract] [Full Text] [Related]

  • 13. [Nephrotic syndrome and LDL apheresis].
    Muso E.
    Nihon Jinzo Gakkai Shi; 2013 Dec; 55(7):1301-13. PubMed ID: 24288967
    [No Abstract] [Full Text] [Related]

  • 14. [Current guidelines for treatment of dyslipidemia in kidney diseases].
    Jędras M, Dylewska M.
    Wiad Lek; 2014 Dec; 67(3):426-8. PubMed ID: 25782205
    [Abstract] [Full Text] [Related]

  • 15. Lipid lowerers.
    Cuddy PG.
    RN; 2006 Aug; 69(8):27-32; quiz 33. PubMed ID: 16939132
    [No Abstract] [Full Text] [Related]

  • 16. An analysis of popular weight loss diet types in relation to metabolic syndrome therapeutic guidelines.
    McClendon DA, Dunbar SB, Clark PC, Coverson DL.
    Medsurg Nurs; 2010 Aug; 19(1):17-24. PubMed ID: 20336980
    [Abstract] [Full Text] [Related]

  • 17. Update on risk factors for atherosclerosis: the role of inflammation and apolipoprotein E.
    Foley SM.
    Medsurg Nurs; 2005 Feb; 14(1):43-50. PubMed ID: 15779740
    [Abstract] [Full Text] [Related]

  • 18. Anaemia and mineral bone disorder in chronic kidney disease: a review of the current literature and implications for clinical nursing practice.
    Limrick C, McNichols-Thomas C.
    J Ren Care; 2009 Mar; 35 Suppl 1():94-100. PubMed ID: 19222739
    [Abstract] [Full Text] [Related]

  • 19. Management of lipid disorders.
    Zarowitz BJ, Aronow WS, Hollenack K, O'Shea T.
    Geriatr Nurs; 2006 Mar; 27(3):142-8. PubMed ID: 16757384
    [No Abstract] [Full Text] [Related]

  • 20. Flash pulmonary edema in patients with chronic kidney disease and end stage renal disease.
    Headley CM, Wall BM.
    Nephrol Nurs J; 2007 Mar; 34(1):15-26, 37; quiz 27-8. PubMed ID: 17345689
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.